Zobrazeno 1 - 10
of 74
pro vyhledávání: '"J J, Seaman"'
Autor:
L S, Rosen, D, Gordon, M, Kaminski, A, Howell, A, Belch, J, Mackey, J, Apffelstaedt, M, Hussein, R E, Coleman, D J, Reitsma, J J, Seaman, B L, Chen, Y, Ambros
Publikováno v:
Cancer journal (Sudbury, Mass.). 7(5)
Zoledronic acid, a new and more potent bisphosphonate, was compared with pamidronate, the current standard treatment for patients with osteolytic or mixed bone metastases/lesions.A total of 1,648 patients with either Durie-Salmon stage III multiple m
Autor:
J R, Berenson, L S, Rosen, A, Howell, L, Porter, R E, Coleman, W, Morley, R, Dreicer, S A, Kuross, A, Lipton, J J, Seaman
Publikováno v:
Cancer. 91(7)
This study evaluated the dose-response relation for zoledronic acid, a new generation high potency bisphosphonate, given as a 5-minute infusion in patients with malignant osteolytic disease.Two-hundred eighty patients with osteolytic lesions due to m
Autor:
A, Lipton, R L, Theriault, G N, Hortobagyi, J, Simeone, R D, Knight, K, Mellars, D J, Reitsma, M, Heffernan, J J, Seaman
Publikováno v:
Cancer. 88(5)
Pamidronate therapy previously has been shown to reduce skeletal complications effectively for up to 12 months in breast carcinoma patients with bone metastases. The current study data provide further follow-up results regarding the effects of long t
Autor:
R L, Theriault, A, Lipton, G N, Hortobagyi, R, Leff, S, Glück, J F, Stewart, S, Costello, I, Kennedy, J, Simeone, J J, Seaman, R D, Knight, K, Mellars, M, Heffernan, D J, Reitsma
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(3)
To assess whether pamidronate can reduce the frequency of skeletal morbidity in women with lytic bone metastases from breast cancer treated with hormone therapy.Three hundred seventy-two women with breast cancer who had at least one lytic bone lesion
Autor:
D, Glover, A, Lipton, A, Keller, A A, Miller, S, Browning, R J, Fram, S, George, K, Zelenakas, R S, Macerata, J J, Seaman
Publikováno v:
Cancer. 74(11)
Treatment of the symptoms of bone metastases currently involves the use of narcotic medication, radiation therapy, or hormonal therapy. Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patien
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 17:248-254
This article discusses normal and abnormal anatomy and physiology of the heart and the techniques used in physical assessment. Specific adverse drug effects are discussed and a case study is provided to illustrate key concepts.
Publikováno v:
Military medicine. 149(5)
Publikováno v:
Drug intelligenceclinical pharmacy. 17(4)
This article discusses normal and abnormal anatomy and physiology of the heart and the techniques used in physical assessment. Specific adverse drug effects are discussed and a case study is provided to illustrate key concepts.
Publikováno v:
Archives of internal medicine. 144(10)
Autor:
Wilson C; University South Carolina Aiken, 471 University Parkway, Aiken, SC 29801, USA., Brigmon RL, Knox A, Seaman J, Smith G
Publikováno v:
Bulletin of environmental contamination and toxicology [Bull Environ Contam Toxicol] 2006 Mar; Vol. 76 (3), pp. 392-9.